Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T15:41:35.037Z.
Calculation as of: 2026-10-06T15:41:35.037Z.
Quote observation: 2026-10-06T15:40:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 4d5e19f74cb926d0196b5f3ffb65db8ff8affa0edec331fa5277d4ca2ec73e8d
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
Decoy Therapeutics Inc.
Market Cap
$853809.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$873508.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$861994.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$832324.00
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$678164.00
Operating Cash Flow Yield
18350.43%
TTM Avg
1695.05%
3Y Avg
1337.72%
5Y Avg
1337.72%
Market Cap
$1.04M
Operating Cash Flow Yield
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$1.06M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.10M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.15M
Operating Cash Flow Yield
N/A
TTM Avg
48.56%
3Y Avg
48.84%
5Y Avg
48.84%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $853809.00 | N/A | N/A | N/A | N/A |
| Bone Biologics Corporation (BBLG)vs › | $873508.00 | N/A | N/A | N/A | N/A |
| GlucoTrack, Inc. (GCTK)vs › | $861994.00 | N/A | N/A | N/A | N/A |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $832324.00 | N/A | N/A | N/A | N/A |
| CDT Equity Inc. (CDT)vs › | $678164.00 | 18350.43% | 1695.05% | 1337.72% | 1337.72% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.04M | N/A | 0.00% | 0.00% | 0.00% |
| Clearmind Medicine Inc. (CMND)vs › | $1.06M | N/A | N/A | N/A | N/A |
| Cellyan Biotechnology Co., Ltd (HKPD)vs › | $1.10M | N/A | N/A | N/A | N/A |
| IM Cannabis Corp. (IMCC)vs › | $1.15M | N/A | 48.56% | 48.84% | 48.84% |
| HCW Biologics Inc. (HCWB)vs › | $549273.00 | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
